Results 141 to 150 of about 53,430 (234)

Drug disposition study on a levofloxacin dry powder formulation using the isolated perfused lung in rats. [PDF]

Sci Rep
Dibaei M, Gholami M, Lavasani H, Sheikholesalmi B, Toliyat T, Barazesh A, Ghazi-Khansari M, Mireskandari K, Rouini M.   +8 more
europepmc   +1 more source

Inhalable gene and RNA therapy for cystic fibrosis: perspectives and progress in clinical development. [PDF]

Nanomedicine (Lond)
Munir M, Butcher NJ, Werder RB, Ranganathan SC, Burow R, Venables A, Kaminskas LM.   +6 more
europepmc   +1 more source

Micro- and Nanoplastics and Pulmonary Health: The Current State of Research. [PDF]

Microplastics
Bardawil CE, Dobbins J, Lankford S, Soloff AC, Dhupar R.   +4 more
europepmc   +1 more source

Experimental Models of Acute Lung Injury to Study Inflammation and Pathophysiology: A Narrative Review. [PDF]

Antioxidants (Basel)
Nagato AC, Machado-Junior PA, Valenca SS, Russo RC, Bezerra FS.   +4 more
europepmc   +1 more source

Therapeutic efficacy of quercetin in experimental pulmonary fibrosis: A meta-analysis. [PDF]

Exp Ther Med
Cai L, Chen L, Lin C.
europepmc   +1 more source

Pulmonary toxicity of polymethyl methacrylate nanoplastics via intratracheal intubation in mice. [PDF]

Sci Rep
Youn C, Jo YJ, Kwon J, Yoon SB, You HJ, Kim JS.   +5 more
europepmc   +1 more source

Clinical characteristics of tracheobronchial mucormycosis: a retrospective analysis of twenty cases. [PDF]

Ann Med
Wu S, Wei Z, He Z, Li M, Zeng W.
europepmc   +1 more source

Therapeutic effects of mesenchymal stromal cells transplantation in animal models of chronic obstructive pulmonary disease: a systematic review and meta-analysis of emphysema and lung inflammation models. [PDF]

Front Cell Dev Biol
Zhao Y, Zhou S, Pei J, Meng Y, Zhang Z.
europepmc   +1 more source

Oxidized mtDNA Contributes to Pulmonary Inflammation and Fibrosis in Bleomycin-Induced Lung Injury. [PDF]

MedComm (2020)
Mao Y, Tian X, Ai J, Zhou X, Ni Y, Wan D, Luo M, Wei X.   +7 more
europepmc   +1 more source

Mini-Catalytically Inactive Cas13X-Derived RNA Base Editing of β-Catenin Attenuates Pulmonary Damage in a Murine Acute Lung Injury Model. [PDF]

MedComm (2020)
Liu W, Bi W, Hou S, Du J, Zeng L, Zhang A, Zhang H, Wen D, Cai Q, Gao C, Lin P, Wu M, Li L, Jiang J.   +13 more
europepmc   +1 more source